---
title: "Hepion Pharmaceuticals acquires ctRNA biomarker assay to detect liver cancer early, with possible applications for other solid tumors."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277623934.md"
description: "A cutting-edge non-invasive diagnostic platform for solid tumor types, including liver cancer, has the potential for applications in a wide range of other tumors. This next-generation platform is poised to revolutionize diagnostics with its innovative approach. It offers a promising alternative for patients, with the potential to improve detection rates and treatment outcomes. This advancement signifies a significant leap forward in the medical field, with the ability to impact numerous individuals affected by various types of solid tumors."
datetime: "2026-03-03T12:36:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277623934.md)
  - [en](https://longbridge.com/en/news/277623934.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277623934.md)
---

# Hepion Pharmaceuticals acquires ctRNA biomarker assay to detect liver cancer early, with possible applications for other solid tumors.

A cutting-edge non-invasive diagnostic platform for solid tumor types, including liver cancer, has the potential for applications in a wide range of other tumors. This next-generation platform is poised to revolutionize diagnostics with its innovative approach. It offers a promising alternative for patients, with the potential to improve detection rates and treatment outcomes. This advancement signifies a significant leap forward in the medical field, with the ability to impact numerous individuals affected by various types of solid tumors.

### Related Stocks

- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [HEPA.US](https://longbridge.com/en/quote/HEPA.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)

## Related News & Research

- [Hepion Pharmaceuticals raises $3.06 million in private placement of 61,100,000 shares at $0.05 each](https://longbridge.com/en/news/294831135.md)
- [Medicare is about to change a drug program that held down the cost of premiums. Here's what to know.](https://longbridge.com/en/news/294391519.md)
- [HEDGE FLOW-Hedge fund bets on rising US healthcare stocks near 5-year high, Goldman says](https://longbridge.com/en/news/293938581.md)
- [Biotech experts want FDA drug reviews based on science, not politics](https://longbridge.com/en/news/293453841.md)
- [IT Sector Accounts for Nearly One Third of U.S. Securities Litigation Risk in 1H 2026](https://longbridge.com/en/news/294507902.md)